Tariff-related Litigation Update – 6/27
IEEPA Tariffs & Legal Challenge Update (6/27/2025)
This members-only briefing details reciprocal tariffs under Executive Order 14257 (as amended) alongside the targeted “fentanyl” tariffs imposed under IEEPA. It also summarizes the latest judicial developments in key challenges—including V.O.S. Selections and Oregon (Fed. Cir. May 28, 2025), Learning Resources (D.C. Cir. May 30 & U.S. June 17, 2025), Emily Ley Paper, Inc. (Ct. Int’l Trade May 23, 2025), Webber (D. Mont. Apr. 4, 2025), and California (N.D. Cal. Apr. 16, 2025).
Related Reading
Resource / Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs
AdvaMed® Advancements: Q2 2025 Report
July 17, 2025
Discover our Q2 report highlighting key industry wins, tariff updates, and strategic progress driving medtech innovation and advocacy forward.
Resource / Emerging Policy Response Resources / Tariffs
Tariff-related Litigation Update – 7/11
July 11, 2025
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through July 11, 2025.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
The Kennedy v Braidwood Ruling: What’s Next for MedTech
July 17, 2025
2:00 PM – 3:30 PM
Join AdvaMed and Reed Smith experts to explore how the Supreme Court’s ACA ruling in Braidwood could shape preventive care and MedTech policy.
Resource / Coverage & Payment / Emerging Policy Response Resources / Global & Trade / Supply Chain / Tariffs
Supreme Court’s Decision in Kennedy v. Braidwood Management, Inc.
July 2, 2025
Explore the impact of the Supreme Court’s decision in Kennedy v. Braidwood on the ACA preventive services mandate and its implications for MedTech policy.
Resource / Emerging Policy Response Resources / Tariffs
Tariff-related Litigation Update – 6/20
June 20, 2025
Member-only summary of IEEPA “fentanyl” and reciprocal tariffs under EO 14257, plus status of related legal challenges across federal courts through June 17, 2025.
Resource / Emerging Policy Response Resources / Tariffs
Tariff-related Litigation Update
June 16, 2025
Explore the latest IEEPA tariff developments and legal challenges, including executive orders on fentanyl tariffs and reciprocal duties affecting global MedTech trade.
Blog / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Tariffs
Medtech is Essential: Industry Supports Call for Tariff Flexibility
May 29, 2025
AdvaMed President and CEO Scott Whitaker testified before the U.S. Senate Finance Committee, bringing attention to the pressing issue of how tariffs could impact the medtech industry and, most importantly, the patients who depend on it.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
URGENT: Court Ruling on Tariffs — Implications for Medtech
Now On Demand!
Emergency Briefing on Court Ruling on Tariffs and Its Impact on Medtech. Now On Demand!